Baker McKenzie advised SIG-i Capital on the deal. SIG-i Capital completed the financing of FLABEG Group. SIG-i Capital is a private credit investment manager which made a...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Seamless Therapeutics GmbH on the deal. Seamless Therapeutics GmbH executed the closing of a $12.5 million Seed Financing, a university carve-out including equity...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Ariceum Therapeutics on the deal. Ariceum Therapeutics (Ariceum) completed a EUR 25 million Series A financing round, co-led by EQT Life Sciences (formerly LSP)...
You must be a Standard 1 Year member to access this content.
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Allecra Therapeutics on the deal. Allecra Therapeutics signed an exclusive licensing agreement with Advanz Pharma Corp. Limited, a specialty pharmaceutical company with a strategic...
You must be a Standard 1 Year member to access this content.
